Molecular Mechanism for Coronary Spastic Angina as a Transcriptional Factor-Related Disease

冠状动脉痉挛性心绞痛作为转录因子相关疾病的分子机制

基本信息

  • 批准号:
    11557053
  • 负责人:
  • 金额:
    $ 8.45万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Cspastic angina is more frequently observed in Japanese than Caucasians. suggesting genctic risk factor is involved in its pathogenesis. In this context, we searched the polymorphisms in endothelial nitic oxide synthase (eNOS) gene, which are associated with coronary srastic angina. We found a missense mutation in exon 7 and a single nucletide polymorphism in the 5-flanking region of eNOS gene, T^<-786>→C Missense mutation in exon7 did not affect eNOS emzyme activity. but T^<-786>→C reduce eNOS gene transcription. To elucidate the molecular mechanism for the reduced eNOS gene transcription, we have now purified a protein that specifically binds to the mutant allele in nuclear extracts from HeLa cells. The purified protein was identical to replication protein A1 (RPA1), known as a single-stranded-DNA binding protein essential for DNA repair. replication and recombination. In human umbilical vein endothelial cells, inhibition of RPA1 expression using antisense oligonucleotide restored transcription driven by the mutated promoter sequence. while conversely, overexpression of RPA1 further reduced it. RPA1 was similarly detected in placenta. and eNOS mRNA levels in placentas carrying the T^<-786>→C mutation were significantly lower than in placentas without it. The functional importance of the diminished eNOS expression was revealed by the finding that serum nitrite/nitrate levels among individuals carrying the T^<-786>→C mutation were significantly lower than among those without the mutation. RPA1 thus apparently functions as a repressor protein in the T^<-786>→C mutation-related reduction of eNOS gene transcription associated with the development of coronary artery disease.
痉挛性心绞痛在日本人中比在高加索人中更常见。提示遗传危险因素参与其发病过程。在此背景下,我们寻找与冠状动脉痉挛性心绞痛相关的内皮型一氧化氮合酶(eNOS)基因多态性。发现eNOS基因第7外显子存在错义突变,5-侧翼区存在单核苷酸多态性,第7外显子T^<-786>→C错义突变不影响eNOS酶活性。而T^<-786>→C则抑制eNOS基因的转录。为了阐明eNOS基因转录减少的分子机制,我们现在已经纯化了一种蛋白质,该蛋白质特异性结合HeLa细胞核提取物中的突变等位基因。纯化的蛋白质与复制蛋白A1(RPA 1)相同,RPA 1是DNA修复所必需的单链DNA结合蛋白。复制和重组。在人脐静脉内皮细胞中,使用反义寡核苷酸抑制RPA 1表达恢复了由突变的启动子序列驱动的转录。而RPA 1的过表达则进一步降低其表达,RPA 1在胎盘组织中的表达也相似。携带T^ →C突变的胎盘中eNOS mRNA水平<-786>显著低于未携带T ^ →C突变的胎盘。携带T^→C突变的个体的血清亚硝酸盐/硝酸盐水平显著低于未携带突变的个体,这一发现揭示了eNOS表达减少的功能重要性<-786>。因此,RPA 1在<-786>与冠状动脉疾病发展相关的eNOS基因转录的T^ →C突变相关的减少中显然起着阻遏蛋白的作用。

项目成果

期刊论文数量(50)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Y.Miyamoto, Y.Saito, M.Nakayama, Y.Shimasaki, T.Yoshimura, M.Yoshimura, M.Harada, N.Kajiyama, L.Kishimoto, K.Kuwahara, J.Hino, E.Ogawa, I.Hamanaka, S.Kamitani, N.Takahashi, R.Kawakami, K.Kangawa, H.Yasue, K.Nakao.: "Replication protein A1 reduces transcri
Y.Miyamoto、Y.Saito、M.Nakayama、Y.Shimasaki、T.Yoshimura、M.Yoshimura、M.Harada、N.Kajiyama、L.Kishimoto、K.Kuwahara、J.Hino、E.Okawa、I。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.Tamura, Y.Ogawa, H.Chusho, K.Nakamura, K.Nakao, M.Suda, M.Kasahara, R.Hashimoto, G.Katsuura, M.Mukoyama. H.Itoh, Y.Saito, I.Tanaka, H.Otani, M.Katsuki, K.Nakao.: "Cardiac fibrosis in mice lacking brain natriuretic peptide."
N.Tamura、Y.Okawa、H.Chosho、K.Nakamura、K.Nakao、M.Suda、M.Kasahara、R.Hashimoto、G.Katsuura、M.Mukoyama。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Mizuno: "Aldosterone Production is Activated in the Failing Ventricles in Humans."Circulation.. 103. 72-77 (2001)
Y.Mizuno:“醛固酮的产生在人类衰竭的心室中被激活。”循环.. 103. 72-77 (2001)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
I.Hamanaka: "Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 Is Involved in gpl30 Resistance in Cardiovascular System in Rat Treated with Cardiotrophin-1 (CT-1) in vivo."Circ.Res.. 88. 727-732 (2001)
I.Hamanaka:“JAB/SOCS-1/SSI-1 和 CIS3/SOCS-3/SSI-3 的诱导参与体内用 Cardiotropin-1 (CT-1) 治疗的大鼠心血管系统中的 gpl30 耐药性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
I.Hamanaka, Y.Saito, H.Yasukawa, L.Kishimoto, K.Kuwahara, Y.Miyamoto, M.Harada, E.Ogawa, N.Kajiyama, N.Takahashi, T.Izumi, R.Kawakami, I.Masuda, A.Yoshimura, K.Nakao.: "Induction of JAB/SOCS-1/SSI-1 and CIS3/SOCS-3/SSI-3 Is Involvedin gp130 Resistance in
I.Hamanaka、Y.Saito、H.Yasukawa、L.Kishimoto、K.Kuwahara、Y.Miyamoto、M.Harada、E.Okawa、N.Kajiyama、N.Takahashi、T.Izumi、R.Kawakami、I.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAITO Yoshihiko其他文献

SAITO Yoshihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAITO Yoshihiko', 18)}}的其他基金

Identifying a factor contributing to gender difference in familial dilated cardiomyopathy
确定导致家族性扩张型心肌病性别差异的因素
  • 批准号:
    25670393
  • 财政年份:
    2013
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Identifying a novel gene contributing to vascular maturation and its significance in cardiovascular diseases.
识别有助于血管成熟的新基因及其在心血管疾病中的意义。
  • 批准号:
    23659424
  • 财政年份:
    2011
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Study for Molecular mechanism of cardiorenal connection.
心肾连接的分子机制研究。
  • 批准号:
    20390227
  • 财政年份:
    2008
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pthophysiological significance of target genes of NRSF, a new transcriptional suppressor, in congestive heart failure
新型转录抑制因子 NRSF 靶基因在充血性心力衰竭中的生理学意义
  • 批准号:
    18390238
  • 财政年份:
    2006
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Involvement of NRSF-mediated Transcriptional Silencing System in Molecular Mechanism of Chronic Heart Failure
NRSF介导的转录沉默系统参与慢性心力衰竭的分子机制
  • 批准号:
    16390228
  • 财政年份:
    2004
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
New Therapeutic Approach for Congestive Heart Failure and Ischemia - reperfusion Injury Based on Cytokine Resistance
基于细胞因子抵抗的充血性心力衰竭和缺血再灌注损伤的治疗新方法
  • 批准号:
    13470144
  • 财政年份:
    2001
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of Molecuolar Mechanism for Cardioprotection-Study from Genetic Engineered Mice
阐明心脏保护的分子机制——基因工程小鼠的研究
  • 批准号:
    11470161
  • 财政年份:
    1999
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Significance of interaction between myocytes and non-myocytes in ventricular hypertrophy.
心肌细胞和非心肌细胞之间相互作用在心室肥厚中的意义。
  • 批准号:
    09470168
  • 财政年份:
    1997
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Clinical Trial of Natriuretic Peptides in Heart Failure
利钠肽治疗心力衰竭的临床试验
  • 批准号:
    08044277
  • 财政年份:
    1996
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Purification of a novel migration factor for vascular smooth muscle cells, derived from omentum and its application
一种新型大网膜血管平滑肌细胞迁移因子的纯化及其应用
  • 批准号:
    08557059
  • 财政年份:
    1996
  • 资助金额:
    $ 8.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了